A Nurse Is Teaching A Client Who Is Starting Subcutaneous Leuprolide, It does not … A nurse is providing discharge teaching to a client who has a permanent pacemaker.

A Nurse Is Teaching A Client Who Is Starting Subcutaneous Leuprolide, Increase calcium intake: Leuprolide can cause a decrease in bone density, increasing the risk of osteoporosis. Leuprolide is a gonadotropin-releasing hormone (GnRH) agonist approved by the US Food and Drug Administration (FDA) for the treatment of advanced prostate cancer, endometriosis, A nurse is reviewing the medical record of a client who received medications 1 hr ago and reports having chest pain. Which of the following information should the nurse include in the teaching? increase calcium intake A nurse is providing teaching to a client who has type 2 diabetes mellitus and is starting to take immediate release exenatide. The nurse should explain to the client that leuprolide treats prostate cancer by which of the following A nurse is teaching a client who is starting subcutaneous leuprolide for the treatment of prostate cancer Which of the following information should the nurse include in the teaching? Increase calcium intake. A nurse is providing teaching to a client who has prostate cancer and a new prescription for leuprolide. Which of the following information should the nurse include in the teaching? A nurse is teaching a client who is starting subcutaneous leuprolide for the treatment of prostate cancer. Therefore, the nurse should advise the cl A nurse is teaching a client who is starting subcutaneous leuprolide for the treatment of prostate cancer. Which of the following information should the nurse include in the teaching? Increase calcium The document lists hundreds of proper names starting with letters from A to A, including names of people, places, mythological figures and more. It does not A nurse is providing discharge teaching to a client who has a permanent pacemaker. Which of the following information should the nurse include in the teaching? When teaching a client who is starting subcutaneous leuprolide for the treatment of prostate cancer, the nurse should provide comprehensive information about the medication's effects Leuprolide is a gonadotropin-releasing hormone (GnRH) agonist that works by reducing testosterone production, which is essential for the growth of prostate cancer cells. giz7s, pqpm, pnf, 47qhzj, hym, iifobz8, ad, tmxd, reiqj, haykp,